BRIVIACT brivaracetam 10mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

briviact brivaracetam 10mg/ml oral solution bottle

ucb australia pty ltd t/a ucb pharma division of ucb australia - brivaracetam, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: sodium citrate dihydrate; purified water; methyl hydroxybenzoate; citric acid; glycerol; carmellose sodium; sorbitol solution (70 per cent) (crystallising); sucralose; flavour - briviact oral solution is indicated as add-on therapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 4 years of age with epilepsy

KEPPRA levetiracetam 100 mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

keppra levetiracetam 100 mg/ml oral solution bottle

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: acesulfame potassium; purified water; maltitol solution; methyl hydroxybenzoate; ammonium glycyrrhizinate; citric acid monohydrate; propyl hydroxybenzoate; sodium citrate dihydrate; glycerol; flavour - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Picolax 10mg / 3.5g / 12 g Powder for Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

picolax 10mg / 3.5g / 12 g powder for oral solution

ferring ireland ltd - sodium picosulphate; magnesium oxide, light ; citric acid, anhydrous - powder for oral solution - 10 mg/3.5 g/12 gram(s) - contact laxatives; sodium picosulfate, combinations

CitraFleet Powder for Oral Solution in sachet Malta - English - Medicines Authority

citrafleet powder for oral solution in sachet

casen recordati, s.l. autovia de logrono, km 13,300, 50180 utebo, zaragoza, spain - sodium picosulfate, magnesium oxide, light, citric acid, anhydrous - powder for oral solution - sodium picosulfate 10 mg magnesium oxide, light 3.5 g citric acid anhydrous 10.97 g - drugs for constipation

Maxibar 98.45% w/w powder for oral suspension Ireland - English - HPRA (Health Products Regulatory Authority)

maxibar 98.45% w/w powder for oral suspension

bracco imaging spa - barium sulfate - powder for oral suspension - 98.45%w/w percent weight/weight - barium sulfate containing x-ray contrast media; barium sulfate with suspending agents

Cefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

cefixime nectar lifesciences 100 mg/5 ml powder for oral suspension

nectar lifesciences uk limited - cefixime - powder for oral suspension - 100/5 milligram(s)/millilitre - cefaclor

Cefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

cefixime nectar lifesciences 100 mg/5 ml powder for oral suspension

neclife pt unipessoal lda - cefixime - powder for oral suspension - 100/5 milligram(s)/millilitre - cefaclor